Chemical Compound Review:
pindolol 1-(1H-indol-4-yloxy)-3- (propan-2...
Synonyms:
Blocklin, Decreten, Pinbetol, Pynastin, Prindolol, ...
- Pindolol and hyperthyroidism. Abadie, E., Leclercq, J.F., Passa, P. N. Engl. J. Med. (1983)
- Endralazine, a new peripheral vasodilator: absence of effect of acetylator status on antihypertensive effect. Holmes, D.G., Bogers, W.A., Wideroe, T.E., Huunan-Seppala, A., Wideroe, B. Lancet (1983)
- Hemodynamic-inotropic response to beta-blocker with intrinsic sympathomimetic activity in patients with congestive cardiomyopathy. Binkley, P.F., Lewe, R.F., Lima, J.J., Al-Awwa, A., Unverferth, D.V., Leier, C.V. Circulation (1986)
- Plasma catecholamine concentrations are a reliable index of sympathetic vascular tone in patients with cirrhosis. Braillon, A., Gaudin, C., Poo, J.L., Moreau, R., Debaene, B., Lebrec, D. Hepatology (1992)
- Lack of efficacy of pindolol in tardive dyskinesia. Greendyke, R.M., Webster, J.C., Kim, J., Kim, H. The American journal of psychiatry. (1988)
- Central nervous system effects of beta-adrenergic-blocking drugs: the role of ancillary properties. Kostis, J.B., Rosen, R.C. Circulation (1987)
- Pindolol potentiation of paroxetine for generalized social phobia: a double-blind, placebo-controlled, crossover study. Stein, M.B., Sareen, J., Hami, S., Chao, J. The American journal of psychiatry. (2001)
- Neuroleptic-induced akathisia treated with pindolol. Reiter, S., Adler, L., Erle, S., Duncan, E. The American journal of psychiatry. (1987)
- Adverse effects of pindolol augmentation in patients with bipolar depression. Yatham, L.N., Lint, D., Lam, R.W., Zis, A.P. Journal of clinical psychopharmacology. (1999)
- Mitchell B. Balter Award--1998. Pindolol and major affective disorders: a three-year follow-up study of 30,485 patients. Räsänen, P., Hakko, H., Tiihonen, J. Journal of clinical psychopharmacology. (1999)
- Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists. Artigas, F., Romero, L., de Montigny, C., Blier, P. Trends Neurosci. (1996)
- Stereoselective renal clearance of pindolol in humans. Hsyu, P.H., Giacomini, K.M. J. Clin. Invest. (1985)
- Selective serotonin reuptake inhibitors plus pindolol. The REEP. Bordet, R., Thomas, P., Dupuis, B. Lancet (1997)
- Is there a third heart beta-adrenoceptor? Kaumann, A.J. Trends Pharmacol. Sci. (1989)
- Hemodynamic and beta-adrenergic receptor adaptations during long-term beta-adrenoceptor blockade. Studies with acebutolol, atenolol, pindolol, and propranolol in hypertensive patients. van den Meiracker, A.H., Man in't Veld, A.J., Boomsma, F., Fischberg, D.J., Molinoff, P.B., Schalekamp, M.A. Circulation (1989)
- New design for clinical trial of antihypertensive drugs applied to pindolol, clopamide, and combinations thereof. Nyberg, G., Asplund, J., Anagreus, N., Aström, B., Leppert, J., Bergström, R., Overmo, J., Kullman, S., Lessem, J. Lancet (1982)
- Acute and long-term studies of the mechanisms of action of beta-blocking drugs in lowering blood pressure. Stumpe, K.O., Kolloch, R., Vetter, H., Gramann, W., Krück, F., Ressel, C., Higuchi, M. Am. J. Med. (1976)
- Chronic effects of labetalol, pindolol, and propranolol on calf blood flow in intermittent claudication. Lepäntalo, M. Clin. Pharmacol. Ther. (1985)
- Improved control of atrial fibrillation with combined pindolol and digoxin therapy. James, M.A., Channer, K.S., Papouchado, M., Rees, J.R. Eur. Heart J. (1989)
- Failure of pindolol and metoprolol to reduce the size of non-reperfused infarcts in dogs using area at risk techniques. Lange, R., Nieminen, M.S., Kloner, R.A. Cardiovasc. Res. (1984)
- Hemodynamic and hormonal adaptations to beta-adrenoceptor blockade. A 24-hour study of acebutolol, atenolol, pindolol, and propranolol in hypertensive patients. van den Meiracker, A.H., Man in 't Veld, A.J., van Eck, H.J., Boomsma, F., Schalekamp, M.A. Circulation (1988)
- Improvement in depressed cardiac function in hypertensive patients during pindolol treatment. Plotnick, G.D., Fisher, M.L., Wohl, B., Hamilton, J.H., Hamilton, B.P. Am. J. Med. (1984)
- Identification of 5-hydroxytryptamine7 receptor binding sites in rat hypothalamus: sensitivity to chronic antidepressant treatment. Sleight, A.J., Carolo, C., Petit, N., Zwingelstein, C., Bourson, A. Mol. Pharmacol. (1995)
- Protection by beta-blocking agents against free radical-mediated sarcolemmal lipid peroxidation. Mak, I.T., Weglicki, W.B. Circ. Res. (1988)
- Activation of the beta 2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6. Ballesteros, J.A., Jensen, A.D., Liapakis, G., Rasmussen, S.G., Shi, L., Gether, U., Javitch, J.A. J. Biol. Chem. (2001)
- 5-HT(1A) agonist potential of pindolol: electrophysiologic studies in the dorsal raphe nucleus and hippocampus. Sprouse, J., Braselton, J., Reynolds, L. Biol. Psychiatry (2000)
- Acceleration of idioventricular rhythms by histamine in guinea pig heart: mediation by H2 receptors. Levi, R., Zavecz, J.H. Circ. Res. (1979)
- Differential actions of serotonin, mediated by 5-HT1B and 5-HT2C receptors, on GABA-mediated synaptic input to rat substantia nigra pars reticulata neurons in vitro. Stanford, I.M., Lacey, M.G. J. Neurosci. (1996)
- Cardioselective and nonselective beta-adrenoceptor blocking drugs in hypertension: a comparison of their effect on blood pressure during mental and physical activity. Floras, J.S., Hassan, M.O., Jones, J.V., Sleight, P. J. Am. Coll. Cardiol. (1985)
- Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity. Serretti, A., Zanardi, R., Rossini, D., Cusin, C., Lilli, R., Smeraldi, E. Mol. Psychiatry (2001)
- Measurement of partial agonist activity of pindolol. Carruthers, S.G., Twum-Barima, Y. Clin. Pharmacol. Ther. (1981)
- [18F]altanserin binding to human 5HT2A receptors is unaltered after citalopram and pindolol challenge. Pinborg, L.H., Adams, K.H., Yndgaard, S., Hasselbalch, S.G., Holm, S., Kristiansen, H., Paulson, O.B., Knudsen, G.M. J. Cereb. Blood Flow Metab. (2004)
- Detection of a novel serotonin receptor subtype (5-HT1E) in human brain: interaction with a GTP-binding protein. Leonhardt, S., Herrick-Davis, K., Titeler, M. J. Neurochem. (1989)
- Pindolol decreases prolactin and growth hormone responses to intravenous L-tryptophan. Smith, C.E., Ware, C.J., Cowen, P.J. Psychopharmacology (Berl.) (1991)
- Pindolol does not act only on 5-HT1A receptors in augmenting antidepressant activity in the mouse forced swimming test. Bourin, M., Redrobe, J.P., Baker, G.B. Psychopharmacology (Berl.) (1998)
- Effect of pindolol on serum lipids and lipid metabolizing enzymes. Lehtonen, A., Hietanen, E., Marniemi, J., Peltonen, P., Niskanen, J. British journal of clinical pharmacology. (1982)
- Drug therapy. Pindolol: a new beta-adrenoceptor antagonist with partial agonist activity. Frishman, W.H. N. Engl. J. Med. (1983)
- No effect of Pindolol on postural hypotension in type 1 (insulin-dependent) diabetic patients with autonomic neuropathy. A randomised double-blind controlled study. Dejgård, A., Hilsted, J. Diabetologia (1988)
- Pindolol augmentation of selective serotonin reuptake inhibitors: PET evidence that the dose used in clinical trials is too low. Rabiner, E.A., Bhagwagar, Z., Gunn, R.N., Sargent, P.A., Bench, C.J., Cowen, P.J., Grasby, P.M. The American journal of psychiatry. (2001)
- Beta-adrenergic receptor blocking drugs in spontaneous hypertension. Levy, J.V. Am. J. Med. (1976)